XML 35 R24.htm IDEA: XBRL DOCUMENT
v3.21.2

Stock-Based Compensation | 6 Months Ended
--- | ---
Jul. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Stock-Based Compensation | NOTE 17 – STOCK-BASED COMPENSATION Under the Company’s Employee Stock Option Plan, as amended and restated as of April 4, 2013 (the “Plan”), the Compensation Committee of the Board of Directors, which consists of three of the Company’s non-employee directors, has the authority to grant participants incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights and stock awards, for up to 11,000,000 shares of common stock. Stock Options: Stock options granted to participants under the plan generally become exercisable after three years and remain exercisable until the tenth anniversary of the date of grant. All stock options granted under the Plan have an exercise price equal to or greater than the fair market value of the Company’s common stock on the grant date. The table below presents the weighted average assumptions used with the Black-Scholes option-pricing model for the calculation of the fair value of stock options granted during the three months ended April 30, 2021. There were no stock options granted during the three months ended July 31, 2021 or during the three and six months ended July 31, 2020.
|  | Six Months Ended July 31, 2021 |
Expected volatility |  |  | 51.61 | %
Expected life in years |  |  | 6.0 |
Risk-free interest rates |  |  | 0.89 | %
Dividend rate |  |  | 2.90 | %
Weighted average fair value per option at date of grant |  | $ | 10.23 |
The fair value of the stock options, less expected forfeitures, is amortized on a straight-line basis over the vesting term. Total compensation expense for stock option grants recognized during the three months ended July 31, 2021 and 2020 was $0.4 million and approximately $27,000, respectively. Total compensation expense for stock option grants recognized during the six months ended July 31, 2021 and 2020 was $0.7 million and $0.1 million, respectively. As of July 31, 2021, there was $3.3 million of unrecognized compensation cost related to unvested stock options. These costs are expected to be recognized over a weighted-average period of 2.4 years. Total consideration received for stock option exercises during the six months ended July 31, 2021 and 2020 was $0.6 million and zero, respectively. The following table summarizes the Company’s stock options activity during the first six months of fiscal 2022:
|  | Outstanding Options |  |  | Weighted Average Exercise Price per Option |  |  | Option Price Per Share |  |  | Weighted Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value $(000) |
Options outstanding at January 31, 2021 (561,110 options exercisable) |  |  | 1,111,110 |  |  | $ | 21.90 |  |  | $12.42-$42.12 |  |  |  | 6.9 |  |  | $ | 2,975 |
Granted |  |  | 201,875 |  |  | $ | 27.62 |  |  | $ | 27.62 |  |  |  |  |  |  |
Exercised |  |  | (24,517 | ) |  | $ | 25.45 |  |  | $23.35-$30.36 |  |  |  |  |  |  |
Cancelled |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |
Options outstanding at July 31, 2021 |  |  | 1,288,468 |  |  | $ | 22.73 |  |  | $12.42-$42.12 |  |  |  | 7.0 |  |  | $ | 10,271 |
Exercisable at July 31, 2021 |  |  | 548,593 |  |  | $ | 28.29 |  |  |  |  |  |  | 3.8 |  |  | $ | 1,785 |
Expected to vest at July 31, 2021 |  |  | 663,115 |  |  | $ | 18.45 |  |  |  |  |  |  | 9.3 |  |  | $ | 7,702 |
The fair value of stock options exercised during the first six months of fiscal 2022 was $0.3 million and the intrinsic value was $0.1 million. There were no stock options exercised during the first six months of fiscal 2021. Stock Awards: Under the Plan, the Company can also grant stock awards to employees and directors. For the three months ended July 31, 2021 and 2020, compensation expense for stock awards was $0.9 million and $1.5 million (of which $0.4 million is included in the Restructuring Plan of the corporate initiatives), respectively. For the six months ended July 31, 2021 and 2020, compensation expense for stock awards was $2.1 million and $3.0 million (of which $0.4 million is included in the Restructuring Plan of the corporate initiatives). As of July 31, 2021, there was $4.5 million of unrecognized compensation cost related to unvested stock awards. These costs are expected to be recognized over a weighted-average period of 2.0 years. The following table summarizes the Company’s stock awards activity during the first six months of fiscal 2022:
|  | Number of Stock Award Units |  |  | Weighted- Average Grant Date Fair Value |  |  | Weighted- Average Remaining Contractual Term (years) |  | Aggregate Intrinsic Value $(000's) |
Units outstanding at January 31, 2021 |  |  | 415,994 |  |  | $ | 29.17 |  |  |  |  |  |
Units granted |  |  | 126,497 |  |  | $ | 27.62 |  |  |  |  |  |
Units vested |  |  | (228,928 | ) |  | $ | 31.49 |  |  |  |  |  |
Units forfeited |  |  | — |  |  | $ | — |  |  |  |  |  |
Units outstanding at July 31, 2021 |  |  | 313,563 |  |  | $ | 26.85 |  |  | 2.1 |  | $ | 9,429 |
Outstanding stock awards can be classified as either time-based stock awards or performance-based stock awards. Time-based stock awards vest over time subject to continued employment. Performance-based stock awards vest over time subject both to continued employment and to the achievement of corporate financial performance goals. Upon the vesting of a stock award, shares are issued from the pool of authorized shares. For performance-based stock awards, the number of shares issued related to the performance units granted can vary from 0% to 150% of the target number of underlying stock award units, depending on the extent of the achievement of predetermined financial goals. The total fair value of stock award units that vested during the first six months of fiscal 2022 was $7.2 million. The number of shares issued related to the remaining stock awards are established at grant date.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration